Using a clinical pathway and education to reduce inappropriate prescribing of enoxaparin in patients with acute coronary syndromes: A controlled study

Internal Medicine Journal

Volumn 36, Issue 1, 2006, Pages 12-18

  Buckmaster, Nicholas D ^a   Heazlewood, V ^b   Scott, I A ^c   Jones, M ^c   Haerer, W ^b   Hillier, K ^b  

^a GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^b CABOOLTURE HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Acute coronary syndromes; Clinical pathway; Critical pathway; Enoxaparin; Low molecular weight heparin; Unstable angina

Indexed keywords

CREATININE; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE DISEASE; ADULT; AGED; AGING; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; EDUCATION PROGRAM; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOEMBOLISM; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANTICOAGULANTS; CRITICAL PATHWAYS; DRUG UTILIZATION; ENOXAPARIN; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; QUEENSLAND; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SYNDROME;

EID: 33644833615     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00989.x     Document Type: Article

References (26)

1. Boufous S, Kelleher PW, Pain CH, Dann LM, Ieraci S, Jalaludin BB et al. Impact of a chest-pain guideline on clinical decision making. Med J Aust 2003; 178: 375-80.
2. Ng SM, Krishnswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS. Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol 2001; 88: 611-17.
3. Aroney CN, Dunlevie HL, Bett JHN. Use of an accelerated chest pain assessment protocol in patients at intermediate risk of adverse cardiac events. Med J Aust 2003; 178: 370-4.
4. Nichol G, Walls R, Goldman L, Pearson S, Hartley LH, Antman E et al. A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med 1997; 127: 996-1005.
5. Holmboe ES, Meehan TP, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Use of critical pathways to improve the care of patients with acute myocardial infarction. Am J Med 1999; 107: 324-31.
6. Cohen M, Demers C, Gurfinkel E, Turpie AGG, Fromell GJ, Goodman S et al. A comparison of LMW heparin with unfractionated heparin for unstable coronary disease. N Engl J Med 1997; 337: 447-52.
7. Antman EM, McCabe C, Gurfinkel EP, Turpie AGG, Bernink PJLM, Salein D et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) IIB trial. Circulation 1999; 100: 1593-601.
8. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premereur J et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI UB - ESSENCE meta-analysis. Circulation 1999; 100: 1602-8.
9. Morrow DA, Antman EM, Tanasijevic M, Nader R, de Lemos JA, McCabe CH et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-IIb substudy. J Am Coll Cardiol 2000; 36: 1812-17.
10. Berkowitz SD, Stinnett S, Cohen M, Fromell GJ, Bigonzi F. Prospective comparison of hemorrhagic complications after 3 treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction. Am J Cardiol 2001; 88: 1230-4.
11. Moscucci M, Fox KAA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-23.
12. Unstable Angina Guideline Writing Group. Management of Unstable Angina Guidelines-2000. Med J Aust 2000; 173 Suppl: S65-88.
13. Theroux P, Walters D, Qiu S, Mccans J, De Guise P, Juneau M. Thrombosis, platelets, and coagulation: aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993; 88: 1045-8.
14. Holdright D, Patel D, Cunningham D, Thoas R, Hubbard W, Hendry G et al. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 1994; 24: 39-45.
15. Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I et al. Acute myocardial infarction/antiplatelet and thrombolytic therapy: combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial. Circulation 1994; 89: 81-8.
16. Theroux P, Ouimet H, McCans J, Latour J, Joly P, Levy G et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988: 319: 1105-11.
17. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA 1996; 276: 811-15.
18. Vaya A, Mira Y, Aznar J, Todoldi J. Enoxaparin-related fatal spontaneous retroperitoneal haematoma in the elderly. Thromb Res 2003; 110: 69-71.
19. Melde SL. Enoxaparin-induced retroperitoneal hematoma. Ann Pharmacother 2003; 37: 822-4.
20. Chan-Tack KM. Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin. South Med J 2003; 96: 58-60.
21. Thorevska N, Amoateng-Adjepong Y, Sabahi R, Schiopescu I, Salloum A, Muralidharan V et al. Anticoagulation in hospitalized patients with renal insufficiency. A comparison of bleeding rates with unfractionated heparin versus enoxaparin. Chest 2004; 125: 856-63.
22. Pearson SD, Goulart-Fischer D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med 1995; 123: 941-8.
23. Scott IA, Buckmaster ND, Harvey KH. Clinical practice guidelines: perspectives of clinicians in Queensland public hospitals. Intern Med J 2003; 33: 273-9.
24. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
25. O'Brien MA, Freemantle N, Oxman AD, Wolf F, Davis DA, Herrin J. Continuing education meetings and workshops: effects on professional practice and health care outcomes (Cochrane review). In: The Cochrane Library, Issue 3, 2004.
26. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-8.